
Merck & Co. bolsters Keytruda production with $1bn US plant
The 470,000 square-foot facility will house laboratory, manufacturing, and warehouse capabilities to support the commercial production of Keytruda and other biologics and therapies, including antibody drug conjugates (ADCs). The facility is expected to …